Scientific GoalsIn pursuit of its mission to build a comprehensive integrated understanding of the regulatory molecular pathways that are used or dysregulated in different types of human malignancies, the Cell Signaling (CS) Program has three specific aims:
- To understand the molecular signaling processes that regulate tumor susceptibility and development and their resistance to treatment.
- To understand the cellular basis of tumor susceptibility, growth and resistance to treatment.
- To develop new technologies that enable discovery.
To achieve these aims, the scientific specialties of CS members include both well-known cancer-associated signaling pathways and others focused on potentially novel targets. Areas of emphasis with potential clinical impact for cancer diagnostics and therapy include:
- Velcade resistance in multiple myeloma and mantle cell lymphoma
- Molecular targets in neuroendocrine tumors, including thyroid cancer
- Drug resistance of tumors treated with DNA damaging agents
- Hormone therapy resistance in breast and prostate cancer
- iPSC lines to minimize graft-versus-host disease during leukemia treatments
- Biomarkers for patients at risk
- Combination therapies for leukemic populations
- Personalized medicine diagnostics